News

Adaptive Research, a CRO focused on putting community physicians into the clinical trial process, has partnered with AHMC Seton Medical Center to expand patient access to new drug studies.Under the terms of the deal, sponsors, CROs and clinical research organizations will be able to use the Daly City, California, medical center for investigative trials if the studies match with Seton’s patient population and the interest of patients in participating, the company said in a March 7 press release. The access is for both in- and outpatient environments at the medical center. Financial terms of the deal weren’t disclosed. View the FIERCE Biotech article here

Through the collaboration, pharmaceutical companies and clinical research organisations can use Seton as a trial site.Integrated clinical trial site organisation Adaptive Research has announced a partnership with AHMC Seton Medical Center for expanding clinical trial access in both in- and out-patient settings.Founded in 1893, Seton Medical Center provides a complete range of medical specialities on inpatient, outpatient, and emergency bases, as well as surgical services.It has been serving the health care requirements of northern San Mateo County and San Francisco.The organisation is recognised for cardio-vascular excellence, stroke treatment, and STEMI certification.Additionally, it offers radiation oncology, acute psychiatry, skilled nursing, laboratory, subacute, wound care, and imaging services for the community.AHMC Seton Coastside operates the only stand-by, 24-hour emergency department located on the Pacific Coast between Daly City and Santa Cruz.Pharmaceutical companies and clinical research organisations (CROs) will be able to use Seton as a clinical trial site through this collaboration.They may use Seton for conducting investigative trials if their studies align with the patient population of the organisation, as well as the interest of the people taking part. AHMC Seton Medical Center administrator Sarkis Vartanian said: “We are excited to partner with Adaptive Research to offer clinical trials on our campus.“At Seton, we pride ourselves on innovation when it comes to patient care and this arrangement provides another unique offering for our community.”In March last year, Adaptive Research announced a collaboration with American Molecular Imaging to add approximately 500 specially trained radiologists to its growing research network.American Molecular Imaging joined the Adaptive Research network to generate better access to clinical trials and provide a path to market for medical products.View Article here

CVS MinuteClinic providers will use Medable’s software platform to improve patient access, engagement and retention during clinical trials. Meanwhile, Thermo Fisher Scientific and Medidata Acorn AI announced a collaboration to develop an application that combines patient recruitment and site performance data for clinical trials.CVS Health, the retail pharmacy which is seeking to overhaul its healthcare strategy, and Palo Alto, California-based software company Medable announced Monday that they’re partnering to expand access to clinical trials through CVS MinuteClinic locations nationwide. The companies did not disclose the financial terms of the partnership. Medical-Commercial Collaborating to Win in the Digital Era  It’s clear that life science companies need to transform their approach to be much more collaborative in the way they work with healthcare professionals. MinuteClinic providers will use Medable’s software platform with the aim of improving patient access, engagement and retention during clinical trials, according to a news release. Based on patient recruitment market research,  less than 4% of the U.S. population participates in clinical trials, something Woonsocket, Rhode Island-based CVS has noted since it began rolling out clinical trial services in May of last year. There are disparities in research participation as well. Clinical trial participants are disproportionately white, though participation among African-Americans increasing. However, other minorities including Asian, Hispanic and Latino groups still consistently underrepresented, according to the clinical data science company Phesi. Patient retention in trials is also a challenge. The vast majority of patients who start a trial don’t complete it. “One of the key reasons is inconvenient location – often the time and economics with taking long trips and time off from work to go to sites that are inconveniently located make trials impossible for some folks, especially in some underrepresented communities,” said Sanskriti Thakur, chief growth officer at Medable, in an email. “This partnership materially changes the way research touches people in the…